0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell Viability Assays Market Insights, Forecast to 2029
Published Date: May 2023
|
Report Code: QYRE-Othe-370
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell Viability Assays Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cell Viability Assays Market Insights, Forecast to 2029

Code: QYRE-Othe-370
Report
May 2023
Pages:110
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell Viability Assays Market Size

The global Cell Viability Assays market is projected to grow from US$ 2702.6 million in 2023 to US$ 3580.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.

Cell Viability Assays Market

Cell Viability Assays Market

Cell Viability Assays is a type of technique used for determining viable cells in the culture. Cell Viability Assays asses the efficiency of the cells by measuring markers of cellular activity. The cell viability is used to monitor the response and health of the cells in the culture after treatment with various stimuli. Moreover, cell Viability Assays and cytotoxicity assays are used for drug screening and cytotoxicity tests of chemicals.
Market Analysis and Insights: Global Cell Viability Assays Market
Numerous factors such as growing prevalence of chronic and infectious diseases, growing availability of funds for cell-based research, rising need of cell-based assays in research and development activities are expected to drive the growth of the market.
Report Includes
This report presents an overview of global market for Cell Viability Assays market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Cell Viability Assays, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cell Viability Assays, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell Viability Assays revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Cell Viability Assays market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Cell Viability Assays revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Merck, Bio-Rad, GE, Danaher, BD, PerkinElmer, Promega and Biotium, etc.

Scope of Cell Viability Assays Market Report

Report Metric Details
Report Name Cell Viability Assays Market
Accounted market size in 2023 US$ 2702.6 million
Forecasted market size in 2029 US$ 3580.6 million
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Human Cells
  • Microbial Cells
  • Animal Cells
Segment by Application
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospital and Diagnostic Laboratories
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Merck, Bio-Rad, GE, Danaher, BD, PerkinElmer, Promega, Biotium, Abcam, Creative Bioarray, Biotek Instruments
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Cell Viability Assays in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell Viability Assays companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Viability Assays revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Viability Assays Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Human Cells
1.2.3 Microbial Cells
1.2.4 Animal Cells
1.3 Market by Application
1.3.1 Global Cell Viability Assays Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Research Institutes
1.3.4 Hospital and Diagnostic Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Viability Assays Market Perspective (2018-2029)
2.2 Global Cell Viability Assays Growth Trends by Region
2.2.1 Cell Viability Assays Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Viability Assays Historic Market Size by Region (2018-2023)
2.2.3 Cell Viability Assays Forecasted Market Size by Region (2024-2029)
2.3 Cell Viability Assays Market Dynamics
2.3.1 Cell Viability Assays Industry Trends
2.3.2 Cell Viability Assays Market Drivers
2.3.3 Cell Viability Assays Market Challenges
2.3.4 Cell Viability Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cell Viability Assays by Players
3.1.1 Global Cell Viability Assays Revenue by Players (2018-2023)
3.1.2 Global Cell Viability Assays Revenue Market Share by Players (2018-2023)
3.2 Global Cell Viability Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cell Viability Assays, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cell Viability Assays Market Concentration Ratio
3.4.1 Global Cell Viability Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Viability Assays Revenue in 2022
3.5 Global Key Players of Cell Viability Assays Head office and Area Served
3.6 Global Key Players of Cell Viability Assays, Product and Application
3.7 Global Key Players of Cell Viability Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Viability Assays Breakdown Data by Type
4.1 Global Cell Viability Assays Historic Market Size by Type (2018-2023)
4.2 Global Cell Viability Assays Forecasted Market Size by Type (2024-2029)
5 Cell Viability Assays Breakdown Data by Application
5.1 Global Cell Viability Assays Historic Market Size by Application (2018-2023)
5.2 Global Cell Viability Assays Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell Viability Assays Market Size (2018-2029)
6.2 North America Cell Viability Assays Market Size by Type
6.2.1 North America Cell Viability Assays Market Size by Type (2018-2023)
6.2.2 North America Cell Viability Assays Market Size by Type (2024-2029)
6.2.3 North America Cell Viability Assays Market Share by Type (2018-2029)
6.3 North America Cell Viability Assays Market Size by Application
6.3.1 North America Cell Viability Assays Market Size by Application (2018-2023)
6.3.2 North America Cell Viability Assays Market Size by Application (2024-2029)
6.3.3 North America Cell Viability Assays Market Share by Application (2018-2029)
6.4 North America Cell Viability Assays Market Size by Country
6.4.1 North America Cell Viability Assays Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Cell Viability Assays Market Size by Country (2018-2023)
6.4.3 North America Cell Viability Assays Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cell Viability Assays Market Size (2018-2029)
7.2 Europe Cell Viability Assays Market Size by Type
7.2.1 Europe Cell Viability Assays Market Size by Type (2018-2023)
7.2.2 Europe Cell Viability Assays Market Size by Type (2024-2029)
7.2.3 Europe Cell Viability Assays Market Share by Type (2018-2029)
7.3 Europe Cell Viability Assays Market Size by Application
7.3.1 Europe Cell Viability Assays Market Size by Application (2018-2023)
7.3.2 Europe Cell Viability Assays Market Size by Application (2024-2029)
7.3.3 Europe Cell Viability Assays Market Share by Application (2018-2029)
7.4 Europe Cell Viability Assays Market Size by Country
7.4.1 Europe Cell Viability Assays Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Cell Viability Assays Market Size by Country (2018-2023)
7.4.3 Europe Cell Viability Assays Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cell Viability Assays Market Size (2018-2029)
8.2 China Cell Viability Assays Market Size by Type
8.2.1 China Cell Viability Assays Market Size by Type (2018-2023)
8.2.2 China Cell Viability Assays Market Size by Type (2024-2029)
8.2.3 China Cell Viability Assays Market Share by Type (2018-2029)
8.3 China Cell Viability Assays Market Size by Application
8.3.1 China Cell Viability Assays Market Size by Application (2018-2023)
8.3.2 China Cell Viability Assays Market Size by Application (2024-2029)
8.3.3 China Cell Viability Assays Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Cell Viability Assays Market Size (2018-2029)
9.2 Asia Cell Viability Assays Market Size by Type
9.2.1 Asia Cell Viability Assays Market Size by Type (2018-2023)
9.2.2 Asia Cell Viability Assays Market Size by Type (2024-2029)
9.2.3 Asia Cell Viability Assays Market Share by Type (2018-2029)
9.3 Asia Cell Viability Assays Market Size by Application
9.3.1 Asia Cell Viability Assays Market Size by Application (2018-2023)
9.3.2 Asia Cell Viability Assays Market Size by Application (2024-2029)
9.3.3 Asia Cell Viability Assays Market Share by Application (2018-2029)
9.4 Asia Cell Viability Assays Market Size by Region
9.4.1 Asia Cell Viability Assays Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Cell Viability Assays Market Size by Region (2018-2023)
9.4.3 Asia Cell Viability Assays Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cell Viability Assays Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Cell Viability Assays Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Cell Viability Assays Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell Viability Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Cell Viability Assays Introduction
11.2.4 Merck Revenue in Cell Viability Assays Business (2018-2023)
11.2.5 Merck Recent Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Cell Viability Assays Introduction
11.3.4 Bio-Rad Revenue in Cell Viability Assays Business (2018-2023)
11.3.5 Bio-Rad Recent Developments
11.4 GE
11.4.1 GE Company Details
11.4.2 GE Business Overview
11.4.3 GE Cell Viability Assays Introduction
11.4.4 GE Revenue in Cell Viability Assays Business (2018-2023)
11.4.5 GE Recent Developments
11.5 Danaher
11.5.1 Danaher Company Details
11.5.2 Danaher Business Overview
11.5.3 Danaher Cell Viability Assays Introduction
11.5.4 Danaher Revenue in Cell Viability Assays Business (2018-2023)
11.5.5 Danaher Recent Developments
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Cell Viability Assays Introduction
11.6.4 BD Revenue in Cell Viability Assays Business (2018-2023)
11.6.5 BD Recent Developments
11.7 PerkinElmer
11.7.1 PerkinElmer Company Details
11.7.2 PerkinElmer Business Overview
11.7.3 PerkinElmer Cell Viability Assays Introduction
11.7.4 PerkinElmer Revenue in Cell Viability Assays Business (2018-2023)
11.7.5 PerkinElmer Recent Developments
11.8 Promega
11.8.1 Promega Company Details
11.8.2 Promega Business Overview
11.8.3 Promega Cell Viability Assays Introduction
11.8.4 Promega Revenue in Cell Viability Assays Business (2018-2023)
11.8.5 Promega Recent Developments
11.9 Biotium
11.9.1 Biotium Company Details
11.9.2 Biotium Business Overview
11.9.3 Biotium Cell Viability Assays Introduction
11.9.4 Biotium Revenue in Cell Viability Assays Business (2018-2023)
11.9.5 Biotium Recent Developments
11.10 Abcam
11.10.1 Abcam Company Details
11.10.2 Abcam Business Overview
11.10.3 Abcam Cell Viability Assays Introduction
11.10.4 Abcam Revenue in Cell Viability Assays Business (2018-2023)
11.10.5 Abcam Recent Developments
11.11 Creative Bioarray
11.11.1 Creative Bioarray Company Details
11.11.2 Creative Bioarray Business Overview
11.11.3 Creative Bioarray Cell Viability Assays Introduction
11.11.4 Creative Bioarray Revenue in Cell Viability Assays Business (2018-2023)
11.11.5 Creative Bioarray Recent Developments
11.12 Biotek Instruments
11.12.1 Biotek Instruments Company Details
11.12.2 Biotek Instruments Business Overview
11.12.3 Biotek Instruments Cell Viability Assays Introduction
11.12.4 Biotek Instruments Revenue in Cell Viability Assays Business (2018-2023)
11.12.5 Biotek Instruments Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Cell Viability Assays Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Human Cells
    Table 3. Key Players of Microbial Cells
    Table 4. Key Players of Animal Cells
    Table 5. Global Cell Viability Assays Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 6. Global Cell Viability Assays Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Cell Viability Assays Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Cell Viability Assays Market Share by Region (2018-2023)
    Table 9. Global Cell Viability Assays Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Cell Viability Assays Market Share by Region (2024-2029)
    Table 11. Cell Viability Assays Market Trends
    Table 12. Cell Viability Assays Market Drivers
    Table 13. Cell Viability Assays Market Challenges
    Table 14. Cell Viability Assays Market Restraints
    Table 15. Global Cell Viability Assays Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Cell Viability Assays Revenue Share by Players (2018-2023)
    Table 17. Global Top Cell Viability Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2022)
    Table 18. Global Cell Viability Assays Industry Ranking 2021 VS 2022 VS 2023
    Table 19. Global 5 Largest Players Market Share by Cell Viability Assays Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Global Key Players of Cell Viability Assays, Headquarters and Area Served
    Table 21. Global Key Players of Cell Viability Assays, Product and Application
    Table 22. Global Key Players of Cell Viability Assays, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Cell Viability Assays Revenue Market Share by Type (2018-2023)
    Table 26. Global Cell Viability Assays Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Cell Viability Assays Revenue Market Share by Type (2024-2029)
    Table 28. Global Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Cell Viability Assays Revenue Share by Application (2018-2023)
    Table 30. Global Cell Viability Assays Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Cell Viability Assays Revenue Share by Application (2024-2029)
    Table 32. North America Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)
    Table 33. North America Cell Viability Assays Market Size by Type (2024-2029) & (US$ Million)
    Table 34. North America Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)
    Table 35. North America Cell Viability Assays Market Size by Application (2024-2029) & (US$ Million)
    Table 36. North America Cell Viability Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. North America Cell Viability Assays Market Size by Country (2018-2023) & (US$ Million)
    Table 38. North America Cell Viability Assays Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Europe Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)
    Table 40. Europe Cell Viability Assays Market Size by Type (2024-2029) & (US$ Million)
    Table 41. Europe Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)
    Table 42. Europe Cell Viability Assays Market Size by Application (2024-2029) & (US$ Million)
    Table 43. Europe Cell Viability Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Europe Cell Viability Assays Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Europe Cell Viability Assays Market Size by Country (2024-2029) & (US$ Million)
    Table 46. China Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)
    Table 47. China Cell Viability Assays Market Size by Type (2024-2029) & (US$ Million)
    Table 48. China Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)
    Table 49. China Cell Viability Assays Market Size by Application (2024-2029) & (US$ Million)
    Table 50. Asia Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)
    Table 51. Asia Cell Viability Assays Market Size by Type (2024-2029) & (US$ Million)
    Table 52. Asia Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)
    Table 53. Asia Cell Viability Assays Market Size by Application (2024-2029) & (US$ Million)
    Table 54. Asia Cell Viability Assays Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 55. Asia Cell Viability Assays Market Size by Region (2018-2023) & (US$ Million)
    Table 56. Asia Cell Viability Assays Market Size by Region (2024-2029) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Type (2018-2023) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Type (2024-2029) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Application (2018-2023) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Application (2024-2029) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Cell Viability Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 62. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country (2018-2023) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Cell Viability Assays Market Size by Country (2024-2029) & (US$ Million)
    Table 64. Thermo Fisher Scientific Company Details
    Table 65. Thermo Fisher Scientific Business Overview
    Table 66. Thermo Fisher Scientific Cell Viability Assays Product
    Table 67. Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 68. Thermo Fisher Scientific Recent Developments
    Table 69. Merck Company Details
    Table 70. Merck Business Overview
    Table 71. Merck Cell Viability Assays Product
    Table 72. Merck Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 73. Merck Recent Developments
    Table 74. Bio-Rad Company Details
    Table 75. Bio-Rad Business Overview
    Table 76. Bio-Rad Cell Viability Assays Product
    Table 77. Bio-Rad Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 78. Bio-Rad Recent Developments
    Table 79. GE Company Details
    Table 80. GE Business Overview
    Table 81. GE Cell Viability Assays Product
    Table 82. GE Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 83. GE Recent Developments
    Table 84. Danaher Company Details
    Table 85. Danaher Business Overview
    Table 86. Danaher Cell Viability Assays Product
    Table 87. Danaher Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 88. Danaher Recent Developments
    Table 89. BD Company Details
    Table 90. BD Business Overview
    Table 91. BD Cell Viability Assays Product
    Table 92. BD Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 93. BD Recent Developments
    Table 94. PerkinElmer Company Details
    Table 95. PerkinElmer Business Overview
    Table 96. PerkinElmer Cell Viability Assays Product
    Table 97. PerkinElmer Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 98. PerkinElmer Recent Developments
    Table 99. Promega Company Details
    Table 100. Promega Business Overview
    Table 101. Promega Cell Viability Assays Product
    Table 102. Promega Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 103. Promega Recent Developments
    Table 104. Biotium Company Details
    Table 105. Biotium Business Overview
    Table 106. Biotium Cell Viability Assays Product
    Table 107. Biotium Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 108. Biotium Recent Developments
    Table 109. Abcam Company Details
    Table 110. Abcam Business Overview
    Table 111. Abcam Cell Viability Assays Product
    Table 112. Abcam Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 113. Abcam Recent Developments
    Table 114. Creative Bioarray Company Details
    Table 115. Creative Bioarray Business Overview
    Table 116. Creative Bioarray Cell Viability Assays Product
    Table 117. Creative Bioarray Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 118. Creative Bioarray Recent Developments
    Table 119. Biotek Instruments Company Details
    Table 120. Biotek Instruments Business Overview
    Table 121. Biotek Instruments Cell Viability Assays Product
    Table 122. Biotek Instruments Revenue in Cell Viability Assays Business (2018-2023) & (US$ Million)
    Table 123. Biotek Instruments Recent Developments
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cell Viability Assays Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Cell Viability Assays Market Share by Type: 2022 VS 2029
    Figure 3. Human Cells Features
    Figure 4. Microbial Cells Features
    Figure 5. Animal Cells Features
    Figure 6. Global Cell Viability Assays Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 7. Global Cell Viability Assays Market Share by Application: 2022 VS 2029
    Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
    Figure 9. Academic and Research Institutes Case Studies
    Figure 10. Hospital and Diagnostic Laboratories Case Studies
    Figure 11. Others Case Studies
    Figure 12. Cell Viability Assays Report Years Considered
    Figure 13. Global Cell Viability Assays Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Cell Viability Assays Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Cell Viability Assays Market Share by Region: 2022 VS 2029
    Figure 16. Global Cell Viability Assays Market Share by Players in 2022
    Figure 17. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by Cell Viability Assays Revenue in 2022
    Figure 19. North America Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America Cell Viability Assays Market Share by Type (2018-2029)
    Figure 21. North America Cell Viability Assays Market Share by Application (2018-2029)
    Figure 22. North America Cell Viability Assays Market Share by Country (2018-2029)
    Figure 23. United States Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Cell Viability Assays Market Size YoY (2018-2029) & (US$ Million)
    Figure 26. Europe Cell Viability Assays Market Share by Type (2018-2029)
    Figure 27. Europe Cell Viability Assays Market Share by Application (2018-2029)
    Figure 28. Europe Cell Viability Assays Market Share by Country (2018-2029)
    Figure 29. Germany Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. France Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. U.K. Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Italy Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Russia Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Nordic Countries Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. China Cell Viability Assays Market Size YoY (2018-2029) & (US$ Million)
    Figure 36. China Cell Viability Assays Market Share by Type (2018-2029)
    Figure 37. China Cell Viability Assays Market Share by Application (2018-2029)
    Figure 38. Asia Cell Viability Assays Market Size YoY (2018-2029) & (US$ Million)
    Figure 39. Asia Cell Viability Assays Market Share by Type (2018-2029)
    Figure 40. Asia Cell Viability Assays Market Share by Application (2018-2029)
    Figure 41. Asia Cell Viability Assays Market Share by Region (2018-2029)
    Figure 42. Japan Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. South Korea Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. China Taiwan Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Southeast Asia Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. India Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Australia Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Cell Viability Assays Market Size YoY (2018-2029) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Cell Viability Assays Market Share by Type (2018-2029)
    Figure 50. Middle East, Africa, and Latin America Cell Viability Assays Market Share by Application (2018-2029)
    Figure 51. Middle East, Africa, and Latin America Cell Viability Assays Market Share by Country (2018-2029)
    Figure 52. Brazil Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Mexico Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Turkey Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Saudi Arabia Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Israel Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. GCC Countries Cell Viability Assays Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 59. Merck Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 60. Bio-Rad Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 61. GE Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 62. Danaher Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 63. BD Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 64. PerkinElmer Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 65. Promega Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 66. Biotium Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 67. Abcam Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 68. Creative Bioarray Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 69. Biotek Instruments Revenue Growth Rate in Cell Viability Assays Business (2018-2023)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmaceutical Autoclaves Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-9U9373
Sat Sep 23 00:00:00 UTC 2023

Add to Cart

Global Pterostilbene Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-38T8768
Sat Sep 23 00:00:00 UTC 2023

Add to Cart

Global Paclitaxel Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-37L8796
Sat Sep 23 00:00:00 UTC 2023

Add to Cart

Global Inosine Pranobex Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-3F9131
Sat Sep 23 00:00:00 UTC 2023

Add to Cart